Skip to main content
. 2020 May 23;69(10):2063–2073. doi: 10.1007/s00262-020-02603-x

Fig. 1.

Fig. 1

Depletion of Tregs can control growth of primary 4T1 tumours and metastatic disease. a The effect of Treg-depletion on primary tumour growth was assessed as outlined. b The number of Tregs present within tumours or c tumour draining lymph nodes 7 days after administration of DTX (4 mice/group). An unpaired t test was performed to determine significance (P = 0.0268). d The average volumes of 4T1 tumours in Treg-depleted and Treg-replete mice are shown (6–7 mice/group). An unpaired two-tailed t test was performed at each time point, giving the following values: day 12 P = 0.0034, day 13 P =  < 0.0001, day 16 p =  < 0.0001 and day 21 p = 0.0002. e The impact of Treg-depletion on metastases following resection of primary tumours was assessed as outlined. f The number of metastatic colonies observed in the lungs of Treg-depleted and Treg-replete mice is shown (17–18 mice/group). A Mann–Whitney test was performed to determine whether there was a statistically significant difference between the groups (p = 0.0162)